HH Medical Inc. v. Walz

Background

HH Medical alleged that Anna Walz and John Walz sold MedEvoke to it under a June 18, 2021 purchase agreement. The Walzes collectively held all of MedEvoke’s membership interests. The agreement identified the purchaser as Apothecom ScopeMedical Inc.; HH Medical identified itself as “HH Medical, Inc., f/k/a Apothecom ScopeMedical Inc.” The opinion states that HH Medical and Apothecom are treated as the same purchaser for purposes of the opinion.

The Walzes warranted that MedEvoke’s financial statements had been prepared in accordance with generally accepted accounting principles and fairly presented the company’s income. The agreement also required the Walzes to indemnify HH Medical for losses arising from a misrepresentation or breach of those warranties. The agreement capped aggregate indemnity payments at 15% of the purchase price, which the court calculated as $3,100,500 based on the $20,670,000 final purchase price.

HH Medical alleged that MedEvoke’s revenue had been improperly recognized and that its 2020 revenue was inflated by $714,000, its revenue from January 1 through March 31, 2021 was inflated by $72,000, and its 2021 net revenue was inflated by approximately $1.2 million. HH Medical alleged that these figures also inflated EBITDA—earnings before interest, taxes, depreciation, and amortization—and caused it to pay more for MedEvoke than the company was worth. It estimated its losses at least $7.8 million but sought at least $3,100,500 under the indemnity provision.

HH Medical notified the Walzes of its indemnification claims on December 15, 2022. The Walzes rejected the claims on January 12, 2023. HH Medical then brought this action asserting one claim for contractual indemnification based on breach of representations and warranties. The Walzes moved to dismiss under Federal Rule of Civil Procedure 12(b)(6), which tests whether a complaint states a legally plausible claim, without deciding the ultimate truth of the allegations.

Court’s Analysis

Reliance on the warranties. The Walzes argued that HH Medical had not alleged that the warranties were the basis of the bargain. The court applied New York law and relied on the New York Court of Appeals’ decision in CBS Inc. v. Ziff-Davis Publishing Co. The court explained that the relevant reliance is reliance on the seller’s promise that the information is accurate, not necessarily belief that the information is true.

The complaint alleged that HH Medical used the financial information to determine MedEvoke’s value and negotiate the purchase price and that the warranties were express terms of the purchase agreement. The court held that these allegations sufficiently showed that the warranties were part of the basis of the bargain. The court also rejected the Walzes’ argument that the complaint was deficient because it did not address HH Medical’s knowledge, finding no indication that the Walzes had disclosed the alleged inaccuracies before closing.

Damages. The Walzes argued that the purchase agreement did not permit HH Medical to recover lost profits, diminution-in-value damages, or consequential damages. The court found that the agreement imposed a clear indemnification duty for losses arising from a misrepresentation or warranty breach.

The court treated HH Medical’s requested damages as diminution-in-value damages: the difference between the price paid for MedEvoke and the company’s actual value at closing. Relying on Powers v. Stanley Black & Decker, Inc., the court stated that diminution-in-value damages are a form of general damages rather than lost profits or consequential damages. It therefore held that the alleged damages fell within the agreement’s definition of “Losses.”

The Walzes also argued that HH Medical could not use an EBITDA multiple without alleging a permanent reduction in MedEvoke’s earnings. The court declined to impose that pleading requirement. Because HH Medical alleged that the parties used an EBITDA multiple to set and negotiate the purchase price and that it used the same method with corrected financial information, the court held that the proposed damages calculation was plausible at the pleading stage.

Proper plaintiff. The purchase agreement named Apothecom ScopeMedical Inc., not HH Medical, as the purchaser. The Walzes argued that HH Medical therefore had not shown that it had an interest in the agreement. HH Medical responded that Apothecom later changed its name to HH Medical and continued as the same legal entity.

The court held that it could reasonably infer from the complaint’s caption, which described the plaintiff as “HH Medical, Inc., f/k/a Apothecom ScopeMedical Inc.,” that HH Medical was the same legal entity as Apothecom. The court therefore found the allegation sufficient at the pleading stage to identify HH Medical as the proper plaintiff.

Disposition

Judge Edgardo Ramos denied the Walzes’ motion to dismiss, Doc. 13. This ruling did not decide whether the alleged warranty breaches occurred or how much HH Medical ultimately may recover; it held only that the complaint stated a plausible contractual indemnification claim. The court also denied HH Medical’s request for oral argument, Doc. 17, as moot, and directed the parties to appear for an initial pretrial conference.